Abstract
PDCD4 is a novel tumor suppressor. Its expression is frequently downregulated in many types of cancers, and it has been demonstrated to inhibit tumor promotion and progression. The biochemical function of PDCD4 is the inhibition of translation through binding to eIF4A helicase. In this review, we will focus on recent advances in understanding the mechanism of inhibiting translation and tumorigenesis by PDCD4, the regulation of PDCD4 expression and the potential application of PDCD4 as a target for cancer diagnostics and therapeutics.
| Original language | English |
|---|---|
| Title of host publication | Translation and Its Regulation in Cancer Biology and Medicine |
| Pages | 135-161 |
| Number of pages | 27 |
| ISBN (Electronic) | 9789401790789 |
| DOIs | |
| State | Published - Mar 1 2014 |
Bibliographical note
Publisher Copyright:© 2014 Springer Science+Business Media Dordrecht. All rights reserved.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Cancer
- Cell signaling
- PDCD4
- RNA helicase
- S6 kinase (S6K)
- Translation initiation
- Tumor suppressor
- eIF4A
- mTOR pathway
- miR-21
ASJC Scopus subject areas
- General Medicine
Fingerprint
Dive into the research topics of 'PDCD4'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver